Clinical Trial Update: Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation study to evaluate the safety and pharmacokinetics of VX-581 in healthy participants, sponsored by Vertex Pharmaceuticals, with cystic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• VX-581

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 1 | Status: RECRUITING